Furthermore, we analyzed the prognostic significance of B7-H3 and GOLM1 in ovarian cancer, which showed that high B7-H3 expression correlated with shorter overall survival (median survival = 37 months vs. 48 months) than patients with low B7-H3 expression (Figure 1(d)), while high GOLM1 expression also correlated with shorter overall survival (median survival = 13.73 months vs. 19 months) than patients with low B7-H3 expression (Figure 1(e)). The gene discussed is CD276; the disease is ovarian cancer.